Industry / China
China Medical City Set To Become The Next Biopharmaceutical Hotspot
October 2011 | Industry Trend AnalysisBMI Core View: Offshoring manufacturing to low cost bases will become increasingly prevalent. Multinational drugmakers are looking to cut costs ahead of the patent cliff and production is being shifted to emerging markets. The key attributes of a manufacturing hub are a favourable tax regime, political stability, a strategic location close to consumers and affordable utilities, real estate and waste management systems.
To read the full article, please choose one of the following options:
Subcribers please log in




